Consistent with slower tumor growth, we observed significantly reduced Ki67 staining (Figure 3D) and mitotic figures (Figure 3E) in end-stage tumors of DT-treated Mac/SCID mice compared to either vehicle-treated Mac/SCID mice or DT-treated non-transgenic mice. Here, MKI67 is linked to neoplasm.